Cresco Labs Inc (CRLBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
Cash Flows From Operating Activities | |||||
Net Income | -23,675 | -296,834 | -284,923 | -21,471 | -24,124 |
Depreciation Amortization | 12,076 | 44,949 | 35,461 | 23,471 | 11,996 |
Income taxes - deferred | -208 | -34,931 | -40,570 | -12,224 | -3,492 |
Accounts receivable | -6,624 | -10,964 | -14,102 | -12,196 | -6,052 |
Other Working Capital | -7,351 | -29,069 | -52,089 | -40,443 | 7,357 |
Other Operating Activity | 22,364 | 341,336 | 333,057 | 32,622 | 27,265 |
Operating Cash Flow | $-3,418 | $14,487 | $-23,166 | $-30,241 | $12,950 |
Cash Flows From Investing Activities | |||||
PPE Investments | -35,588 | -93,875 | -76,539 | -50,690 | -21,410 |
Net Acquisitions | -1,085 | -75,745 | -21,814 | -2,762 | -71 |
Purchase Sale Intangibles | -1,886 | -3,178 | -2,666 | -2,186 | -1,459 |
Other Investing Activity | 2,454 | 5,687 | -1,473 | -2,925 | -5,309 |
Investing Cash Flow | $-34,219 | $-163,933 | $-99,826 | $-56,377 | $-26,790 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | -556 | N/A | N/A | N/A | N/A |
Debt Issued | N/A | 511,105 | 511,105 | 124,105 | 124,105 |
Debt Repayment | N/A | -206,461 | -200,000 | N/A | N/A |
Common Stock Issued | 2,424 | 20,096 | 18,443 | 17,621 | 14,991 |
Other Financing Activity | -8,233 | -89,735 | -92,168 | -60,210 | -6,890 |
Financing Cash Flow | $-6,365 | $235,005 | $237,380 | $81,516 | $132,206 |
Exchange Rate Effect | -180 | -231 | -365 | -439 | -169 |
Beginning Cash Position | 226,102 | 140,774 | 140,774 | 140,774 | 140,774 |
End Cash Position | 181,920 | 223,543 | 254,797 | 135,233 | 258,971 |
Net Cash Flow | $-44,182 | $82,769 | $114,023 | $-5,541 | $118,197 |
Free Cash Flow | |||||
Operating Cash Flow | -3,418 | 14,487 | -23,166 | -30,241 | 12,950 |
Capital Expenditure | -35,588 | -93,875 | -76,539 | -50,690 | -21,410 |
Free Cash Flow | -39,006 | -79,388 | -99,705 | -80,931 | -8,460 |